Sunday, November 28, 2021
Pfizer BioNTech - We will issue modified vaccines against Omicron in 100 days, if its current vaccine is ineffective against it
Pfizer BioNTech announced that they are collecting all the required information about the “Omicron” variant caused by the Corona virus (Covid-19), to inspect the possibility of modifying our vaccines. Trending : Saudi Arabia allows direct entries from all countries for those who received 1 dose of vaccine in Saudi Arabia with 3 days quarantine
"We will be able to export modified vaccines against the new variant within 100 days," Pfizer BioNTech added. Pfizer spokesman said, we expects to know within 2 weeks, whether the variant is resistant to our current vaccine or may require any adjustment in it.
- Moderna said it plans to test a variant-specific booster in cases its current vaccine is found to be ineffective against Omicron. Johnson and Johnson also testing the effectiveness of its vaccine against Omicron variant. Recommend : Ministry of Health again recommends wearing a mask in these places
- Meanwhile, The World Health Organization (WHO) held a meeting of experts to evaluate the new Corona virus. The European Commission has proposed suspending flights from southern Africa due to the detection of a new mutant of Covid-19.
- Britain has expressed great concern about the new strain of the Corona virus, as the Health Security Agency said that the strain called “B1.1.529” contains a so-called “spike protein” completely different from the protein found in the original Corona virus, based on which vaccines made.
- According to British newspaper, The Guardian, 50 confirmed cases of the new mutant (omicron) were detected in South Africa, Hong Kong and Botswana. Follow Saudi Expatriates on Telegram
- As per the scientists, the variant has a range of mutations that raise concern because they can help it avoid the body's immune response and make it more transmissible.
